| Trends in peptide drug discovery M Muttenthaler, GF King, DJ Adams, PF Alewood Nature Reviews Drug Discovery 20, 309–325, 2021 | 1179 | 2021 |
| The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms BG Fry, K Roelants, DE Champagne, H Scheib, JDA Tyndall, GF King, ... Annual Review of Genomics and Human Genetics 10, 483-511, 2009 | 898 | 2009 |
| Venoms as a platform for human drugs: translating toxins into therapeutics GF King Expert Opinion on Biological Therapy 11, 1469-1484, 2011 | 602 | 2011 |
| Spider-venom peptides: structure, pharmacology, and potential for control of insect pests GF King, MC Hardy Annual Review of Entomology 58, 475-496, 2013 | 422 | 2013 |
| Spider-venom peptides as therapeutics NJ Saez, S Senff, JE Jensen, SY Er, V Herzig, LD Rash, GF King Toxins 2, 2851-2871, 2010 | 349 | 2010 |
| A rational nomenclature for naming peptide toxins from spiders and other venomous animals GF King, MC Gentz, P Escoubas, GM Nicholson Toxicon 52, 264-276, 2008 | 329 | 2008 |
| Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain JD Osteen, V Herzig, J Gilchrist, JJ Emrick, C Zhang, X Wang, J Castro, ... Nature 534, 494–499, 2016 | 297 | 2016 |
| Membrane localization of MinD is mediated by a C-terminal motif that is conserved across eubacteria, archaea, and chloroplasts TH Szeto, SL Rowland, LI Rothfield, GF King Proceedings of the National Academy of Sciences USA 99, 15693-15698, 2002 | 264 | 2002 |
| Macromolecular NMR spectroscopy for the non‐spectroscopist AH Kwan, M Mobli, PR Gooley, GF King, JP Mackay FEBS Journal 278, 687-703, 2011 | 262 | 2011 |
| Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads JK Klint, S Senff, DB Rupasinghe, SY Er, V Herzig, GM Nicholson, ... Toxicon 60, 478-491, 2012 | 255 | 2012 |
| Venomics: a new paradigm for natural products-based drug discovery I Vetter, JL Davis, LD Rash, R Anangi, M Mobli, PF Alewood, RJ Lewis, ... Amino Acids 40, 15-28, 2011 | 255 | 2011 |
| Spider-venom peptides as bioinsecticides MJ Windley, V Herzig, SA Dziemborowicz, MC Hardy, GF King, ... Toxins 4, 191-227, 2012 | 252 | 2012 |
| Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach P Escoubas, B Sollod, GF King Toxicon 47, 650-663, 2006 | 247 | 2006 |
| Structural basis for the modulation of voltage-gated sodium channels by animal toxins H Shen, Z Li, Y Jiang, X Pan, J Wu, B Cristofori-Armstrong, JJ Smith, ... Science 362, eaau2596, 2018 | 239 | 2018 |
| Tandem use of selective insecticides and natural enemies for effective, reduced-risk pest management MC Gentz, G Murdoch, GF King Biological Control 52, 208-215, 2010 | 238 | 2010 |
| Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. X Wang, M Connor, R Smith, MW Maciejewski, MEH Howden, ... Nature Structural Biology 7, 505–513, 2000 | 234 | 2000 |
| Were arachnids the first to use combinatorial peptide libraries? BL Sollod, D Wilson, O Zhaxybayeva, JP Gogarten, R Drinkwater, GF King Peptides 26, 131-139, 2005 | 232 | 2005 |
| The structure of a novel insecticidal neurotoxin, ω-atracotoxin-HV1, from the venom of an Australian funnel web spider JI Fletcher, R Smith, SI O'Donoghue, M Nilges, M Connor, MEH Howden, ... Nature Structural Biology 4, 559-566, 1997 | 232 | 1997 |
| Venomics as a drug discovery platform P Escoubas, GF King Expert Review of Proteomics 6, 221-224, 2009 | 215 | 2009 |
| Discovery of a selective Nav1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models S Yang, Y Xiao, D Kang, J Liu, Y Li, EAB Undheim, JK Klint, M Rong, ... Proceedings of the National Academy of Sciences USA 110, 17534-17539, 2013 | 214 | 2013 |
Volker HerzigAssociate Professor, University of the Sunshine CoastVerifisert e-postadresse på usc.edu.au
